These models develop tissue-specific lesions that arise from a single alteration in KRAS and evolve, through acquisition of additional mutations, until the development of macroscopic adenocarcinomas, in a process that resembles the natural development of cancer in humans. This evidence concerns the gene KRAS and cancer.